These outcomes, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 aid the notion of targeting ACKR3 as a novel way to modulate the opioid system, which could open up new therapeutic avenues for opioid-associated disorders. Balanced joints enable us to https://henryq480ywt1.theobloggers.com/profile